Works by Zhou, Longen


Results: 7
    1

    Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40631-0
    By:
    • Leung, Elaine Lai-Han;
    • Li, Run-Ze;
    • Fan, Xing-Xing;
    • Wang, Lily Yan;
    • Wang, Yan;
    • Jiang, Zebo;
    • Huang, Jumin;
    • Pan, Hu-Dan;
    • Fan, Yue;
    • Xu, Hongmei;
    • Wang, Feng;
    • Rui, Haopeng;
    • Wong, Piu;
    • Sumatoh, Hermi;
    • Fehlings, Michael;
    • Nardin, Alessandra;
    • Gavine, Paul;
    • Zhou, Longen;
    • Cao, Yabing;
    • Liu, Liang
    Publication type:
    Article
    2
    3
    4
    5
    6

    Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC‐1.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35665
    By:
    • Cai, Zhen;
    • Xia, Zhongjun;
    • He, Ai‐Li;
    • Dong, Yu‐Jun;
    • Wang, Yafei;
    • Liao, Aijun;
    • Song, Yang;
    • Song MM, Juanjuan;
    • Uhlar, Clarissa;
    • Chastain, Katherine;
    • Watkins, Latisha;
    • Luo, Xinchao;
    • Huang, Lin;
    • Niu, Zhuolu;
    • Quijano Cardé, Natalia A.;
    • Guo, Yue;
    • Xu, Hongmei;
    • Verona, Raluca I.;
    • Zhou, Longen;
    • Li, Jingyun
    Publication type:
    Article
    7